Lisinopril/hydrochlorothiazide

Lisinopril/hydrochlorothiazide
Combination of
Lisinopril	ACE inhibitor
Hydrochlorothiazide	Thiazide diuretic
Clinical data
MedlinePlus	a601070
Pregnancy category	US: D (Evidence of risk)
Legal status	℞ (Prescription only)
Routes of administration	Oral
Identifiers
ATC code	C09BA03
(verify)

Lisinopril/hydrochlorothiazide (trade name Prinzide by Merck & Co., Zestoretic by AstraZeneca, and many others) is a combination of the drugs lisinopril, an ACE inhibitor, and hydrochlorothiazide, a diuretic. It is used to control hypertension.

References

Drugs.com: Prinzide
Drugs.com: Zestoretic

Antihypertensives: agents acting on the renin–angiotensin system (C09)

ACE inhibitors ("-pril")	Sulfhydryl-containing: Captopril Rentiapril Zofenopril Dicarboxylate-containing: Enalapril^# Benazepril Cilazapril Delapril Imidapril Lisinopril (+HCT) Moexipril Perindopril Quinapril (+HCT) Ramipril Spirapril Temocapril Trandolapril Phosphonate-containing: Fosinopril (+HCT) Other/ungrouped: Alacepril

AIIRAs/ ("-sartan")	Azilsartan Candesartan Eprosartan Fimasartan Irbesartan Losartan (+HCT) Olmesartan (+amlodipine) Tasosartan^§ Telmisartan (+HCT) Valsartan (+HCT, +amlodipine, +sacubitril)

Renin inhibitors/ ("-kiren")	Aliskiren (+amlodipine, +amlodipine and HCT) Remikiren^§

^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

This article is issued from Wikipedia - version of the Tuesday, January 29, 2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.